FRANKLIN RESOURCES INC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
FRANKLIN RESOURCES INC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$283,795
+23.8%
10,021
+0.4%
0.00%
Q1 2023$229,241
-19.0%
9,980
-0.9%
0.00%
Q4 2022$282,850
+23.5%
10,073
+24.8%
0.00%
Q3 2022$229,000
-95.1%
8,070
-92.1%
0.00%
-100.0%
Q4 2018$4,689,000
+5.9%
101,700
+77.2%
0.00%
+50.0%
Q3 2018$4,427,000
-8.4%
57,4000.0%0.00%0.0%
Q2 2018$4,835,000
+3.0%
57,4000.0%0.00%0.0%
Q1 2018$4,694,000
+31.4%
57,400
-8.2%
0.00%0.0%
Q4 2017$3,573,000
-17.7%
62,500
-3.8%
0.00%0.0%
Q3 2017$4,339,000
-80.3%
65,000
-81.9%
0.00%
-80.0%
Q3 2014$22,000,000
+10.0%
358,600
-17.8%
0.01%
+11.1%
Q2 2014$20,000,000
+6.8%
436,500
-8.7%
0.01%0.0%
Q1 2014$18,725,000
+55.9%
478,300
-4.6%
0.01%
+50.0%
Q4 2013$12,011,000
-31.7%
501,500
-20.3%
0.01%
-33.3%
Q3 2013$17,598,000629,4000.01%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 965,369$56,378,00014.98%
Casdin Capital, LLC 237,500$13,870,0008.18%
BB BIOTECH AG 2,839,528$165,828,0005.42%
Opaleye Management Inc. 130,000$7,592,0003.78%
Redmile Group, LLC 902,578$52,711,0003.42%
Clarius Group, LLC 109,230$6,379,0002.63%
Opus Point Partners Management, LLC 57,410$3,353,0002.49%
Ghost Tree Capital, LLC 125,000$7,300,0001.36%
CAPITAL INTERNATIONAL LTD /CA/ 346,937$20,261,0001.32%
Eventide Asset Management 300,800$17,567,0001.16%
View complete list of AGIOS PHARMACEUTICALS INC shareholders